Clinical efficacy of topical ophthalmic application of Guduchi Ghrita versus sodium chromoglycate 2% eye drops in Vernal Keratoconjunctivitis

Department of Shalakya Tantra0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年2月6日

研究概览

暂无简介。

•1.Males or females 4 to 18 years of age.
•2.Active VKC
•3.Patients were required to have experienced 1 or more recurrences of VKC during the previous year.
•4.Only the patients (or patientâ??s guardian) who consent to be included in the study and sign on the consent form attached as annexure 1 will be included in the study.

•1.Patients will be excluded if they demonstrated ocular anomalies other than VKC affecting the ocular surface.
•2.Abnormalities of lid anatomic features, nasolacrimal drainage, or blinking function.
•3.Active ocular infection or history of ocular herpes, varicella zoster or vaccinia virus infection.
•4.Any ocular disease that would require topical ocular treatment during the study.
•5.Presence or history of severe systemic allergy at study entry.
•6.Topical or systemic corticosteroids within 1 week; topical or systemic immunosuppressive drug within 90 days before enrolment.
•7.Scraping of the vernal plaque within 1 month; or any other ocular surgery within 6 months before baseline.

发起方

Department of Shalakya Tantra